A carregar...
Angiotensin receptor blockers in heart failure after the ELITE II trial
<p>Abstract</p> <p>Specific blockers of the angiotensin type1 receptor, angiotensin receptor blockers (ARBs), have been introduced as an alternative to angiotensin-converting enzyme inhibitors (ACEi) for the treatment of heart failure. In comparison with ACEi, ARBs are better toler...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BMC
2000-09-01
|
Colecção: | Current Controlled Trials in Cardiovascular Medicine |
Assuntos: | |
Acesso em linha: | http://cvm.controlled-trials.com/content/1/1/079 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|